Less Ads, More Data, More Tools Register for FREE

Pin to quick picksC&C Group Regulatory News (CCR)

Share Price Information for C&C Group (CCR)

Share Price is delayed by 15 minutes
Get Live Data
94.50    2.30 (2.49%)
Bid:
94.10
Ask:
94.40
Spread: 0.30 (0.319%)
Market Cap: £348.08m
CCR Live PriceLast checked at - London Stock Exchange

Intraday C&C Group Share Chart

Trading Statement

7 Mar 2019 07:00

C&C Group Plc(β€œC&C” or the β€œGroup”)

Period end trading update for the 12 months ended 28 February 2019

Dublin, London | 7 March, 2019:Β Following from its trading update of 10 January, 2019, C&C today reports that Group EBIT, for the 12-month period to 28 February, 2019 (β€˜FY19’), is now expected to be towards the upper end of current market estimates and full year adjusted EPS growth is anticipated to be c.20%.

Operational delivery, customer service and the underlying cash contribution of both Matthew Clark and Bibendum in the second half have continued to improve. Consequently, Group year-end net debt is now expected to be well below current market estimates, within a range of €305m - €312m.

Matthew Clark and Bibendum have significant underlying momentum, across key financial and performance measures, with good progress made on the identification of synergy benefits. In our Scottish and Irish and branded businesses, positive trading momentum continued. The sponsorship of next week’s Cheltenham Gold Cup by our Irish cider brands, Magners and Bulmers will build on this momentum and demonstrates the ambition we have for these brands.

C&C will host a capital markets day with the announcement of its FY19 results on 22 May, 2019, at which the Group will provide its medium-term outlook together with the underlying assumptions.

ENDS

Contacts

C&C Group plcStephen Glancey | Group Chief ExecutiveJonathan Solesbury | Chief Financial OfficerJoe Thompson | Head of Investor RelationsTel: +44 7980 844 580Email: Joe.Thompson@candcgroup.com

FTI ConsultingJonathan Neilan/Paddy BerkeryTel: +353 1 765 0884Email: CandCGroup@fticonsulting.com

Novella CommunicationsTim Robertson/Toby AndrewsTel: +44 203 151 7008Email: TimR@novella-comms.com

_____________________________________________________________________________________________________________________

About C&C Group plc

C&C Group plc is a leading, vertically integrated premium drinks company which manufactures, markets and distributes branded beer, cider, wine, spirits, and soft drinks across the UK and Ireland.

C&C Group’s portfolio of owned/exclusive brands include: Bulmers, the leading Irish cider brand; Tennent’s, the leading Scottish beer brand; Magners the premium international cider brand; as well as a range of fast-growing, super-premium and craft ciders and beers, such as Heverlee, Menabrea and Orchard Pig. C&C Group has owned brand and contract manufacturing/packing operations in Co.Tipperary, Ireland; Glasgow, Scotland; and Vermont, US, where it manufactures Woodchuck, a leading craft cider brand in the United States. C&C is the No.#1 drinks distributor to the UK and Ireland hospitality sectors. Operating under the Matthew Clark, Bibendum, Tennent's and C&C Gleeson brands, the Group supplies over 35,000 pubs, bars, restaurants and hotels, and is a key route-to-market for major international beverage companies. C&C Group also has a minority investment in the Admiral Taverns tenanted pub group, which owns over 800 pubs across England & Wales and exports its Magners and Tennent’s brands to over 60 countries worldwide.

C&C Group is headquartered in Dublin and is listed on the Irish and London Stock Exchanges.

Note regarding forward-looking statements

This announcement includes forward-looking statements, including statements concerning current expectations about future financial performance and economic and market conditions which C&C believes are reasonable. However, these statements are neither promises nor guarantees, but are subject to risks and uncertainties, including those factors discussed on page 16 of our Interim results for the six months ended 31 August 2018, that could cause actual results to differ materially from those anticipated.

View source version on businesswire.com: https://www.businesswire.com/news/home/20190306005740/en/

Copyright Business Wire 2019

Date   Source Headline
3rd Jun 20263:59 pmRNSHolding(s) in Company
2nd Jun 20265:19 pmRNSHolding(s) in Company
2nd Jun 202612:04 pmRNSHolding(s) in Company
1st Jun 20266:18 pmRNSTotal Voting Rights
28th May 20264:30 pmRNSHolding(s) in Company
28th May 202610:40 amRNSDirector/PDMR Shareholding
27th May 20264:43 pmRNSHolding(s) in Company
19th May 20263:54 pmRNSDirector/PDMR Shareholding
19th May 20267:00 amRNSFinal Results
8th May 20267:00 amRNSHolding(s) in Company
7th May 20265:28 pmRNSHolding(s) in Company
1st May 20264:28 pmRNSHolding(s) in Company
1st May 20264:25 pmRNSTotal Voting Rights
30th Apr 20264:49 pmRNSHolding(s) in Company
29th Apr 202611:14 amRNSHolding(s) in Company
29th Apr 202611:05 amRNSHolding(s) in Company
16th Apr 20264:37 pmRNSDirector/PDMR Shareholding
9th Apr 202612:12 pmRNSChief Financial Officer Update
1st Apr 202611:58 amRNSTotal Voting Rights
20th Mar 20265:42 pmRNSBoard Committee Membership Update
17th Mar 20263:30 pmRNSDirector/PDMR Shareholding
13th Mar 202612:33 pmRNSHolding(s) in Company
6th Mar 20261:15 pmRNSAcquisition of Innis & Gunn Brand
2nd Mar 202611:31 amRNSTotal Voting Rights
24th Feb 20261:09 pmRNSDirectorate change
18th Feb 202611:56 amRNSDirector/PDMR Shareholding
6th Feb 202612:34 pmRNSDirector/PDMR Shareholding
5th Feb 20267:02 amRNSAppointment of Chief Financial Officer
2nd Feb 202612:55 pmRNSTotal Voting Rights
23rd Jan 20267:00 amRNSFY26 Trading Update
19th Jan 20265:26 pmRNSDirector/PDMR Shareholding
9th Jan 20263:21 pmRNS2025 AGM Voting Update Statement
5th Jan 202611:40 amRNSTotal Voting Rights
23rd Dec 20255:53 pmRNSDirector/PDMR Shareholding
23rd Dec 20255:53 pmRNSDirector/PDMR Shareholding
22nd Dec 20251:12 pmRNSHolding(s) in Company
22nd Dec 20251:12 pmRNSHolding(s) in Company
17th Dec 202512:36 pmRNSDirector/PDMR Shareholding
17th Dec 202512:36 pmRNSDirector/PDMR Shareholding
10th Dec 20256:08 pmRNSHolding(s) in Company
1st Dec 20253:27 pmRNSTotal Voting Rights
26th Nov 202511:40 amRNSHolding(s) in Company
24th Nov 20254:38 pmRNSHolding(s) in Company
19th Nov 20254:46 pmRNSDirector/PDMR Shareholding
19th Nov 202510:45 amRNSDirector/PDMR Shareholding
18th Nov 20253:30 pmRNSDirector/PDMR Shareholding
14th Nov 202511:19 amRNSHolding(s) in Company
13th Nov 20251:45 pmRNSHolding(s) in Company
3rd Nov 20253:09 pmRNSTotal Voting Rights
28th Oct 20257:00 amRNSInterim Results

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.